Arturo Molina MD

Arturo Molina MD is a declared insider at 3 companies; the most frequent names are Protagonist Therapeutics, Inc, Sutro Biopharma, Inc. and Forma Therapeutics Holdings, Inc. In total, 48 filings cover trades dated from 26 September 2019 to 26 March 2026.

In open-market terms, that means 1 purchase worth €46k on one side and 16 sales worth €7.8M on the other. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 14 share grants and 16 option exercises. 2026 to date brings no purchases and 5 sales.

The record was last updated on 27 March 2026 with an open-market sale (€1.4M) in Protagonist Therapeutics, Inc. The latest purchase dates back some time: it was published 2,353 days ago, on 14 May 2020. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.